Education Tools to Support Pediatric Survivor Care

Cancer Clinical Trial

Official title:

Evaluating Education Tools to Support Pediatric Cancer Survivor Care Across the Lifespan (Administrative Supplement to R01CA218389)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04257058
• Other study ID #: IRB00091839
• Secondary ID: R01CA218389
• Status: Recruiting
• Phase: N/A
• Start date: June 7, 2022
• Est. completion date: May 2024

Study information

• Verified date: April 2024
• Source: Emory University
• Contact: Jordan Marchak, PhD
• Phone: 404-727-2293
• Email: jgillel[@]emory.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to evaluate the impact of electronic educational materials on adolescent and young adult ("AYA") survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.

Description:

Despite increased risk for morbidity and mortality related to cancer treatment, over half of young adult survivors of childhood cancer do not engage in the recommended healthcare designed to detect late effects and secondary cancers. There is a scarcity of data on adherence to survivor-focused healthcare, particularly at the critical transition from pediatrics to adult care. In order to improve transition outcomes, the investigators need to create media to educate survivors about need for adherence to adult survivor healthcare.

This study aims to evaluate the impact of electronic educational materials on AYA survivors' knowledge about late effects, perceived benefits, self-efficacy, and intentions to engage in lifelong survivor care.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 58
• Est. completion date: May 2024
• Est. primary completion date: May 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 25 Years

Eligibility

Inclusion Criteria:

• Patients must be 18-25 years of age,

• Diagnosed with cancer at = 18 years of age,

• = 2 years since the last cancer treatment,

• seen at least once in the Aflac CSP in the past 2 years or transitioned out of the Aflac CSP to adult survivor care since 2013.

Exclusion Criteria:

• Patients and/or parents will be excluded from participation in the study if the participant is non-English speaking.

• Young adult survivors who are cognitively impaired and unable to complete the questionnaires.

• Participants that do not consent to the recording of their interviews.

Related Conditions & MeSH terms

• Cancer
• Pediatric Cancer

Intervention

Behavioral:
• Electronic educational material
Electronic media via email

Locations

Country	Name	City	State
United States	Children's Healthcare of Atlanta	Atlanta	Georgia

Sponsors (2)

Lead Sponsor	Collaborator
Emory University	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in knowledge	Knowledge will be assessed at baseline and 2 weeks post-intervention, with the Survivor Care Knowledge scale, that includes 15-item multiple-choice quiz to assess participants' knowledge of the content covered in the electronic educational materials previously provided. Total score ranges from 0-15. Higher score is associated with better outcome.	Baseline, 2 weeks post-intervention
Secondary	Change in Champion Benefits Scale for Mammography screening	5-item study adapted Champion Benefits Scale for Mammography Screening. Total score ranges from 5-25. Lower score equals fewer perceived benefits of survivor care	Baseline, 2 weeks post-intervention
Secondary	Change in Champion Barriers Scale for Mammography Screening	11-item study adapted Champion Barriers Scale for Mammography Screening. Total score ranges from 11-55. Lower score equals fewer perceived barriers to survivor care	Baseline, 2 weeks post-intervention
Secondary	Change in Champion Susceptibility Scale for Mammography Screening	3-item study adapted Champion Susceptibility Scale for Mammography Screening. Total score ranges from 3-15. Lower score equals less susceptibility to late effects of treatment	Baseline, 2 weeks post-intervention
Secondary	Change in Intentions for survivor care	2-item study adapted Ajzen's Theory of Planned Behavior- Intentions. Total score ranges from 2-14. Lower score equals greater intention to engage in long-term follow-up care	Baseline, 2 weeks post-intervention
Secondary	Change in Perceived Health Competence Scale (PHCS)	8-item Perceived Health Competence Scale (PHCS). total score ranges from 8-40. Lower score equals lower perceived health competence	Baseline, 2 weeks post-intervention